CFS Investment Advisory Services, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1845688 TOTOWA, NJ

Position in GILD

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$1,473,124

-$227,886 QoQ

Shares Held

11,660

-4.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.55%

of 13F equity value

Holder Rank

#935

of 2,266 holders

Holding Since

Jun 2023

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CFS Investment Advisory Services, LLC holds $28,816,926 across 9 Drug Manufacturers - General names. GILD ranks #6 (5.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	29,062	$7,380,876
2	ABBV	AbbVie Inc.	24,175	$6,083,397
3	LLY	ELI LILLY & Co	4,838	$5,802,842
4	MRK	Merck & Co., Inc.	26,467	$3,401,009
5	AMGN	Amgen Inc	9,251	$3,349,972
6	GILD	Gilead Sciences, Inc. This page	11,660	$1,473,124
7	BMY	Bristol Myers Squibb Co	9,415	$542,492
8	PFE	Pfizer Inc	16,411	$395,176

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,473,124	11,660	-4.5%	Shares	Sole	2026-07-16
2026-03-31	$1,701,010	12,205	+5.2%	Shares	Sole	2026-04-29
2025-12-31	$1,424,274	11,604	+1.4%	Shares	Sole	2026-02-10
2025-09-30	$1,269,951	11,441	+3.1%	Shares	Sole	2025-10-31
2025-06-30	$1,229,880	11,093	+0.8%	Shares	Sole	2025-08-11
2025-03-31	$1,233,334	11,007	-1.3%	Shares	Sole	2025-05-12
2024-12-31	$1,029,648	11,147	-0.3%	Shares	Sole	2025-01-21
2024-09-30	$937,582	11,183	+1.9%	Shares	Sole	2024-11-12
2024-06-30	$752,857	10,973	+63.1%	Shares	Sole	2024-08-13
2023-06-30	$518,449	6,727	—	Shares	Sole	2023-07-21
No filing history on record for this holder in this stock.